Posted Feb. 6, 2013 at 9:22 a.m.

Premium Lock GSK: Cost-cutting focus is on Europe, not US

Published: 2013-02-06 09:22:36
Updated: 2013-02-06 09:22:36

GSK's R&D facility in RTP    GSK's R&D facility in RTP. (GSK photo)

In looking to reduce costs by $1.57 billion a year through 2016, GlaxoSmithKline is focusing on Europe, not U.S. where many changes have already been made, a GSK spokesperson says....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders